Sanofi CEO explains R&D strategy and investment plan

04/12/2011 | American City Business Journals

Sanofi-Aventis CEO Chris Viehbacher said he wants to improve research and development without opening another R&D center, which he said can be resource-intensive and unproductive. He also wants the company to co-invest with private-equity firms in startups as well as ramp up collaboration and acquisition to promote innovation in various diseases. The R&D strategy was unveiled as Viehbacher took over as CEO of Genzyme, which Sanofi acquired for $20.1 billion.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX